U.S. market Closed. Opens in 1 day 6 hours 2 minutes

NAVB | Navidea Biopharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue65.65K531.51K915.01K26.62K322.52K
Cost of Revenue184.95K198.83K1.05K6.67K96.64K
Gross Profit-119.30K332.68K913.97K19.95K225.88K
Operating Expenses13.93M12.59M11.63M10.98M11.07M
Selling, General & Admin7.96M7.45M6.69M6.28M7.70M
Research & Development5.97M5.14M4.93M5.34M4.22M
Other Operating ExpensesN/A-14.12K-21.86K-631.21K1.15K
Operating Income-14.05M-12.06M-10.71M-10.96M-10.85M
Other Expenses / Income-1.13M345.52K-10.51K17.68K-5.32M
Before Tax Income-15.18M-11.71M-10.72M-10.94M-16.17M
Income Tax ExpensesN/A16.04K-81.74K707.002.75K
Net Income-15.18M-11.73M-10.64M-10.95M-16.13M
Interest Expenses1.10M6.36KN/A25.29K30.80K
Basic Shares Outstanding29.34M29.34M23.90M14.39M8.53M
Diluted Shares Outstanding30.90M29.34M23.90M14.39M8.53M
EBITDA-13.88M-11.51M-10.64M-10.82M-10.85M
EBITDA Margin-21,134.32%-2,164.89%-1,162.91%-40,641.69%-3,363.29%
EBIT-14.08M-11.71M-10.72M-10.92M-16.09M
EBIT Margin-21,444.63%-2,202.87%-1,171.75%-41,023.19%-4,989.72%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙